Incremental prognostic value of left ventricular function by myocardial ecg-gated fdg pet imaging in patients with ischemic cardiomyopathy

BackgroundThe purpose of this study was to determine the independent value of left ventricular (LV) functional parameters derived from gated fluorine 18 fluorodeoxyglucose (FDG) positron emission tomography (PET) to predict prognosis in patients with ischemic cardiomyopathy undergoing myocardial viability assessment.Methods and ResultsWe studied 90 consecutive patients with coronary artery disease and low LV ejection fraction (26% ± 7%) undergoing gated FDG PET to assess myocardial viability for potential revascularization. The primary endpoint for this analysis was the occurrence of cardiac death, myocardial infarction, or worsening heart failure (HF) to New York Heart Association class IV. During follow-up (22 ± 14 months), 21 patients had an event (17 died, 4 had myocardial infarctions, and 4 had worsening HF). On Cox regression analysis, the event-free survival rate at 2 years was lower for patients with an end-diastolic volume (EDV) of 260 mL or greater (relative risk, 2.7; P = .014), end-systolic volume (ESV) of 200 mL or greater (relative risk, 2.5; P = .021), and LV mass of 143 g or greater (relative risk, 1.6; P = .009). In a risk-adjusted model, EDV (_x2 = 68, P < .0001) and ESV (x2 = 75, P = .035) added a significant amount in the estimation of events over the perfusion-FDG mismatch pattern (x2 = 40, P < .001). In a stratified Cox model, patients with PET mismatch, LV ejection fraction lower than 25%, and EDV of 260 mL or greater had the lowest survival rate (P = .006). These patients showed an apparent survival benefit with revascularization but without an improvement in HF symptoms.ConclusionLV functional parameters determined by gated FDG PET have incremental prognostic value over viability information in patients with ischemic cardiomyopathy. Our data suggest that patients with residual viability and advanced cardiac remodeling are at high clinical risk. In these patients the apparent survival benefit of revascularization may not be associated with a measurable improvement in HF symptoms.

[1]  N. Danchin,et al.  Long-term prediction of major ischemic events by exercise thallium-201 single-photon emission computed tomography. Incremental prognostic value compared with clinical, exercise testing, catheterization and radionuclide angiographic data. , 1995, Journal of the American College of Cardiology.

[2]  H. Adachi,et al.  Left ventricular volume predicts postoperative course in patients with ischemic cardiomyopathy. , 1998, The Annals of thoracic surgery.

[3]  M. Schwaiger,et al.  Clinical outcome of patients with advanced coronary artery disease after viability studies with positron emission tomography. , 1992, Journal of the American College of Cardiology.

[4]  M E Phelps,et al.  Identification and Differentiation of Resting Myocardial Ischemia and Infarction in Man with Positron Computed Tomography, 18F‐labeled Fluorodeoxyglucose and N‐13 Ammonia , 1983, Circulation.

[5]  H. Schelbert,et al.  Long-term survival of patients with coronary artery disease and left ventricular dysfunction: implications for the role of myocardial viability assessment in management decisions. , 1998, The Journal of thoracic and cardiovascular surgery.

[6]  H. White,et al.  End‐Systolic Volume and Long‐term Survival After Coronary Artery Bypass Graft Surgery in Patients With Impaired Left Ventricular Function , 1994, Circulation.

[7]  M. Phelps,et al.  Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy. , 1995, Circulation.

[8]  D. Berman,et al.  Incremental prognostic value of post-stress left ventricular ejection fraction and volume by gated myocardial perfusion single photon emission computed tomography. , 1999, Circulation.

[9]  E G DePuey,et al.  Echocardiographic validation of gated SPECT ventricular function measurements. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[10]  M. Emond,et al.  Long‐term Survival of Medically Treated Patients in the Coronary Artery Surgery Study (CASS) Registry , 1994, Circulation.

[11]  L. Armadans,et al.  Prognostic assessment of uncomplicated first myocardial infarction by exercise echocardiography and Tc-99m tetrofosmin gated SPECT , 2001, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

[12]  D. Berman,et al.  The economic consequences of available diagnostic and prognostic strategies for the evaluation of stable angina patients: an observational assessment of the value of precatheterization ischemia. Economics of Noninvasive Diagnosis (END) Multicenter Study Group. , 1999, Journal of the American College of Cardiology.

[13]  F. Harrell,et al.  Observational Comparison of Event‐Free Survival With Medical and Surgical Therapy in Patients With Coronary Artery Disease: 20 Years of Follow‐up , 1992, Circulation.

[14]  V. Hasselblad,et al.  A metaanalysis of predischarge risk stratification after acute myocardial infarction with stress electrocardiographic, myocardial perfusion, and ventricular function imaging. , 1996, The American journal of cardiology.

[15]  M. Carli.  Assessment of myocardial viability after myocardial infarction , 2002 .

[16]  R. Bonow.  Myocardial viability and prognosis in patients with ischemic left ventricular dysfunction. , 2002, Journal of the American College of Cardiology.

[17]  R. Coleman,et al.  Prognosis by measurements of left ventricular function during exercise. Duke Noninvasive Research Working Group. , 1998, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[18]  R M Whitlock,et al.  Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. , 1987, Circulation.

[19]  J. Udelson.  Steps forward in the assessment of myocardial viability in left ventricular dysfunction. , 1998, Circulation.

[20]  Diao Mf.  Predicting improved function after myocardial revascularization. , 1998 .

[21]  L. Stevenson,et al.  Ischemic cardiomyopathy. Criteria for coronary revascularization and cardiac transplantation. , 1991, Circulation.

[22]  M Schwaiger,et al.  Reversibility of cardiac wall-motion abnormalities predicted by positron tomography. , 1986, The New England journal of medicine.

[23]  W. J. Maclntyre,et al.  Prognosis of Patients With Left Ventricular Dysfunction, With and Without Viable Myocardium After Myocardial Infarction: Relative Efficacy of Medical Therapy and Revascularization , 1994, Circulation.

[24]  D. Berman,et al.  Incremental prognostic value of myocardial perfusion single photon emission computed tomography for the prediction of cardiac death: differential stratification for risk of cardiac death and myocardial infarction. , 1998, Circulation.

[25]  L. Shaw,et al.  Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis. , 2002, Journal of the American College of Cardiology.

[26]  S. Chae,et al.  Independent and incremental prognostic value of exercise single-photon emission computed tomographic (SPECT) thallium imaging in coronary artery disease. , 1993, Journal of the American College of Cardiology.

[27]  M. Phelps,et al.  Value of metabolic imaging with positron emission tomography for evaluating prognosis in patients with coronary artery disease and left ventricular dysfunction. , 1994, The American journal of cardiology.

[28]  R. Pettigrew,et al.  Three-dimensional displays of left ventricular epicardial surface from standard cardiac SPECT perfusion quantification techniques. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[29]  J. Votaw,et al.  Comparison of 2-dimensional and 3-dimensional cardiac 82Rb PET studies. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[30]  I. Ringqvist,et al.  Survival of Medically Treated Patients in the Coronary Artery Surgery Study (CASS) Registry , 1982, Circulation.